Cargando…
Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes
The addition of TGF-beta to cultures of LPS-stimulated murine B cells causes a approximately 10-fold enhancement of IgA production, yet causes a 10-fold decrease in total Ig production. IL-2 and, to a lesser extent, IL-5 synergize with TGF-beta to further enhance IgA production and partially reverse...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189449/ https://www.ncbi.nlm.nih.gov/pubmed/2788703 |
_version_ | 1782146644869906432 |
---|---|
collection | PubMed |
description | The addition of TGF-beta to cultures of LPS-stimulated murine B cells causes a approximately 10-fold enhancement of IgA production, yet causes a 10-fold decrease in total Ig production. IL-2 and, to a lesser extent, IL-5 synergize with TGF-beta to further enhance IgA production and partially reverse the inhibition of total Ig production. IgA constitutes only approximately 0.1% of total Ig in LPS-stimulated cultures, but that percentage rises to 15-25% in cultures to which TGF- beta and IL-2 are added. TGF-beta induces a substantial increase in IgA production from sIgA- B cells but inhibits IgA production by sIgA+ cells. This finding suggests that TGF-beta acts as an isotype-specific switch factor for IgA. |
format | Text |
id | pubmed-2189449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1989 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21894492008-04-17 Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes J Exp Med Articles The addition of TGF-beta to cultures of LPS-stimulated murine B cells causes a approximately 10-fold enhancement of IgA production, yet causes a 10-fold decrease in total Ig production. IL-2 and, to a lesser extent, IL-5 synergize with TGF-beta to further enhance IgA production and partially reverse the inhibition of total Ig production. IgA constitutes only approximately 0.1% of total Ig in LPS-stimulated cultures, but that percentage rises to 15-25% in cultures to which TGF- beta and IL-2 are added. TGF-beta induces a substantial increase in IgA production from sIgA- B cells but inhibits IgA production by sIgA+ cells. This finding suggests that TGF-beta acts as an isotype-specific switch factor for IgA. The Rockefeller University Press 1989-09-01 /pmc/articles/PMC2189449/ /pubmed/2788703 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes |
title | Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes |
title_full | Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes |
title_fullStr | Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes |
title_full_unstemmed | Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes |
title_short | Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes |
title_sort | transforming growth factor beta specifically enhances iga production by lipopolysaccharide-stimulated murine b lymphocytes |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189449/ https://www.ncbi.nlm.nih.gov/pubmed/2788703 |